To evaluate the diversity of common AML-related mutations (FLT3-ITD, NPM1, DNMT3A,) in CD34+/- subpopulations within the same patient, 4 patients co-expressing these 3 mutations were selected for assessment (Pts.1-4, Fig. 5b). The gene discussed is NPM1; the disease is acute myeloid leukemia.